CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 712 shares at $15.67 ($11,157)
- 4 Open-market sale EVP and COO sold 356 shares at $15.67 ($5,579)
- 4 Open-market sale Chief Financial Officer sold 752 shares at $15.67 ($11,784)
- 4 Open-market sale Chief Scientific Officer sold 1,186 shares at $15.67 ($18,585)
- 4 Exercise or conversion Chief Financial Officer acquired 68,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 1,098 shares at $11.75 ($12,902)
- 4 Open-market sale EVP and COO sold 330 shares at $11.75 ($3,878)
Page 9 of 14 · 274 filings